Assessment of the relative benefits of monotherapy and combination therapy approaches to the treatment of hospital-acquired Stenotrophomonas maltophilia pneumonia: a multicenter, observational, real-world study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessment of the relative benefits of monotherapy and combination therapy approaches to the treatment of hospital-acquired Stenotrophomonas maltophilia pneumonia: a multicenter, observational, real-world study
Authors
Keywords
-
Journal
Annals of Intensive Care
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-06-07
DOI
10.1186/s13613-023-01144-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole on Achromobacter, Burkholderia, and Stenotrophomonas isolates
- (2023) Edeer Iván Montoya-Hinojosa et al. Expert Review of Anti-Infective Therapy
- Risk factors of lower respiratory tract infection caused by Stenotrophomonas maltophilia: Systematic review and meta-analysis
- (2023) Yiwei Wang et al. Frontiers in Public Health
- Infection dynamics of Stenotrophomonas maltophilia in patients with cystic fibrosis
- (2023) Beverley C. Millar et al. JOURNAL OF INFECTION
- Taxonomic position, antibiotic resistance and virulence factor production by Stenotrophomonas isolates from patients with cystic fibrosis and other chronic respiratory infections
- (2022) Ad C. Fluit et al. BMC MICROBIOLOGY
- Clinical Characteristics, Outcomes, and Risk Factors for Mortality in Patients with Stenotrophomonas maltophilia Bacteremia
- (2022) Siripen Kanchanasuwan et al. Journal of Clinical Medicine
- Risk Factors for Mortality in Hospitalized Patients with Stenotrophomonas maltophilia Bacteremia
- (2022) Jiyong Jian et al. Infection and Drug Resistance
- Stenotrophomonas maltophilia Epidemiology, Resistance Characteristics, and Clinical Outcomes: Understanding of the Recent Three Years’ Trends
- (2022) Taghreed A. Hafiz et al. Microorganisms
- Combination Therapy versus Monotherapy in the Treatment of Stenotrophomonas maltophilia Infections: A Systematic Review and Meta-Analysis
- (2022) Abhisit Prawang et al. Antibiotics-Basel
- Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate
- (2021) Mohammed Alsuhaibani et al. Antimicrobial Resistance and Infection Control
- Impact of the inclusion of an aminoglycoside to the initial empirical antibiotic therapy for Gram-negative bloodstream infections in hematological neutropenic patients: a propensity-matched cohort study (AMINOLACTAM study)
- (2021) A Albasanz-Puig et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Perspectives on Antimicrobial Agents: Cefiderocol
- (2021) Erin K. McCreary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Assessment of Mortality-Related Risk Factors and Effective Antimicrobial Regimens for Treatment of Bloodstream Infections Caused by Carbapenem-Resistant Enterobacterales
- (2021) Liang Chen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Advances in the Microbiology of Stenotrophomonas maltophilia
- (2021) Joanna S. Brooke CLINICAL MICROBIOLOGY REVIEWS
- Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy
- (2021) Shauna Jacobson Junco et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The Potential of Phage Therapy against the Emerging Opportunistic Pathogen Stenotrophomonas maltophilia
- (2021) Jaclyn G. McCutcheon et al. Viruses-Basel
- Tigecycline in the Treatment of Ventilator-Associated Pneumonia Due to Stenotrophomonas maltophilia: A Multicenter Retrospective Cohort Study
- (2021) Lei Zha et al. Infectious Diseases and Therapy
- Impact of Empirical Antibiotic Regimens on Mortality in Neutropenic Patients with Bloodstream Infection Presenting with Septic Shock
- (2021) Mariana Chumbita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections
- (2021) Pranita D Tamma et al. CLINICAL INFECTIOUS DISEASES
- Effect of antibiotic therapy on the prognosis of ventilator-associated pneumonia caused by Stenotrophomonas maltophilia
- (2021) Bérénice Puech et al. Annals of Intensive Care
- Stenotrophomonas maltophilia Infections: Clinical Characteristics and Factors Associated with Mortality of Hospitalized Patients
- (2020) Worachart Insuwanno et al. Infection and Drug Resistance
- Treatment of Community-Acquired Pneumonia in Immunocompromised Adults
- (2020) Julio A. Ramirez et al. CHEST
- Augmented Renal Clearance
- (2019) Aaron M. Cook et al. PHARMACOTHERAPY
- Efficacy of combination therapy versus monotherapy in the treatment of Stenotrophomonas maltophilia pneumonia
- (2019) Megan D Shah et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children
- (2019) Itay Tokatly Latzer et al. Pediatric Critical Care Medicine
- Heteroresistance: A cause of unexplained antibiotic treatment failure?
- (2019) Victor I. Band et al. PLoS Pathogens
- Ventilator-associated pneumonia due to Stenotrophomonas maltophilia: Risk factors and outcome
- (2019) Wafa Ibn Saied et al. JOURNAL OF INFECTION
- Pneumonia mortality, comorbidities matter?
- (2019) Venceslau Pinto Hespanhol et al. Pulmonology
- Heterogeneous Colistin-Resistance Phenotypes Coexisting in Stenotrophomonas maltophilia Isolates Influence Colistin Susceptibility Testing
- (2018) Sònia Martínez-Servat et al. Frontiers in Microbiology
- Stenotrophomonas maltophilia – a low-grade pathogen with numerous virulence factors
- (2018) Angelina Trifonova et al. Infectious Diseases
- Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia : in vitro effects and clinical efficacy in cancer patients
- (2017) Hideki Araoka et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
- (2016) Andre C. Kalil et al. CLINICAL INFECTIOUS DISEASES
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- (2016) Mervyn Singer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments
- (2016) Chuanqi Wei et al. PLoS One
- Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
- (2014) Stella G Muthuri et al. Lancet Respiratory Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started